Regard
AI that surfaces undocumented diagnoses in the workflow
Our take
Regard, founded in 2017 as HealthTensor and based in Los Angeles, embeds an AI chart reviewer inside the EHR that reads the entire patient record and surfaces diagnoses the care team may have missed, then drafts the supporting documentation. Because it runs concurrently during the inpatient stay rather than after discharge, physicians can confirm a suggested diagnosis and treat it, which is the wedge that separates it from pre-bill and CDI tools that only fix the paperwork afterward.
The company raised a $61M Series B led by Oak HC/FT in July 2024 at a $350M valuation, bringing total funding above $80M. It reports more than three million diagnoses surfaced and over $50M in incremental revenue for partners including Banner Health (rolling out across 33 hospitals) and Sentara (all 12 hospitals after 2-4x ROI pilots), with Cedars-Sinai and WakeMed added as marquee partners in 2025. Its position is distinctive: a clinical tool with a hard revenue-integrity business case, sold to systems that want both.
What it does
- Reviews the full patient chart inside the EHR
- Surfaces missed or undocumented diagnoses to clinicians
- Drafts clinical notes with supporting evidence linked
- Runs concurrently during the stay, not post-discharge
- Improves documentation for both revenue and quality metrics
Where it's strong
- Works concurrently inside the clinician's Epic workflow, so diagnoses are captured while the physician can still act on them, unlike post-discharge review tools.
- Multi-year, system-wide proof: Sentara scaled to all 12 hospitals after 2-4x ROI, and Banner rolled it toward 33 hospitals.
- Cedars-Sinai is investor, development partner, and customer, giving unusual clinical depth for a company this size.
What buyers should weigh
- Requires physician adoption to deliver value, a harder change-management lift than back-office tools your clinicians never see.
- Smaller war chest (roughly $80M raised) than several competitors chasing the same documentation dollars.
- Value proposition mixes clinical decision support with revenue capture; make sure your compliance team is comfortable with how diagnosis suggestions are framed.
Latest
In 2025 Sentara Health scaled Regard across all 12 of its hospitals after 2-4x ROI in pilots, and Cedars-Sinai announced a formal partnership in September 2025 to cut documentation burden.
Also in Revenue Integrity & Pre-Bill Review
SmarterDx
Pre-bill AI review that finds missed revenue and quality
Iodine Software
Clinical AI for documentation integrity and utilization review
Accuity
Physician-led pre-bill chart review that recovers earned revenue
Evidently
EHR-embedded AI that turns scattered chart data into answers
Track this market
First Pass covers Revenue Integrity & Pre-Bill Review and the rest of the getting-paid stack every week.